TipRanks
Go Ultimate55% OFF

Robert DeMichiei Insider Profile

4 Followers

Robert DeMichiei, Director at Ardent Health Partners, Inc., holds 35.56K shares in Ardent Health Partners, Inc. (Ticker: ARDT), holds 46.20K shares in Waystar Holding Corp. (Ticker: WAY), holds 85.56K shares in Ampco-Pittsburgh (Ticker: AP). Most recently, Robert DeMichiei Bought ― shares of Ardent Health Partners, Inc. on Jun 08, 2026 for an estimated value of $98.30K.

Robert DeMichiei's Trading History

ARDT
Ardent Health Partners, Inc.
Jun 08, 2026DirectorInformative Buy98.30K$427.83K
WAY
Waystar Holding Corp.
Jun 03, 2026DirectorUninformative Buy―$1.29M
AP
Ampco-Pittsburgh
May 18, 2026DirectorUninformative Buy―$658.80K

You May Also Like

Robert DeMichiei insider profile FAQ

What is the percentage of profitable transactions made by Robert DeMichiei?
The percentage of profitable transactions made by Robert DeMichiei is 100%.
What is the average return per transaction made by Robert DeMichiei?
The average return per transaction made by Robert DeMichiei is 26.30%.
What stocks does Robert DeMichiei hold?
Robert DeMichiei holds: ARDT, AP, WAY stocks.
What was Robert DeMichiei’s latest transaction?
Robert DeMichiei’s latest transaction was an Informative Buy of $98.30K.
What was Robert DeMichiei's most profitable transaction?
Robert DeMichiei’s most profitable transaction was an Informative Buy of ARDT stock on June 8, 2026. The return on the trade was 36.20%.
What is Robert DeMichiei's role in Ardent Health Partners, Inc.?
Robert DeMichiei's role in Ardent Health Partners, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.